Pediatric Bipolar Disorder and ADHD Have Shared Neural Substrate Alterations
Pediatric bipolar disorder (PBD) and attention-deficit/hyperactivity disorder (ADHD) were found to have both shared and distinct alterations in gray matter volumes (GMVs). These findings from a systematic review and meta-analysis were published in the Journal of the American Academy of Child & Adolescent Psychiatry.
Read MoreNo, You Don’t Have Adult ADHD. You’re Probably Just Distracted.
Key Takeaways: ADHD is often misdiagnosed and goes untreated in adults. There’s no evidence that technology or social media use causes adults to develop ADHD. Mental health conditions like anxiety and depression often overlap with ADHD, so it is important for adults to get the right diagnosis and treatment.
Read MorePhase 3 Trial Data Supports Efficacy of Novel Treatment for ADHD in Adults
CONFERENCE REPORTER: Investigators found in recent research that centanafadine sustained release is an effective treatment for adults with attention-deficit/hyperactivity disorder (ADHD) regardless of patient treatment history. They shared these results in a poster presentation at the 2024 American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting.
Read MoreUnique Motivations and Patters (sic) of Substance Use in Individuals With ADHD
CONFERENCE REPORTER: Individuals with attention-deficit/hyperactivity (ADHD) show distinct motivations and patterns of substance use. Additionally, treating ADHD symptoms does not decrease an individual’s likelihood of misusing substances. The poster, “Substance Use Motives and Patterns in People With and Without ADHD,” presented at the American Professional Society of ADHD and Related Disorders 2024 conference sought to…
Read MoreWhat We’re Getting Wrong About Nutrition and Mental Health (Opinion)
A growing body of evidence links the consumption of unhealthy and ultra-processed foods with an increase in mental health conditions like depression and anxiety. A 2022 study found that the more ultra-processed foods a participant consumed, the more likely they were to report anxiety and depression. Other studies have linked poor diet to conditions like…
Read MoreADHD Symptoms Linked With Physical Comorbidities
Investigators from the French Health and Medical Research Institute (INSERM), University of Bordeaux, and Charles Perrens Hospital, alongside their Canadian, British, and Swedish counterparts, have shown that attention deficit disorder hyperactivity disorder (ADHD) or attention deficit disorder without hyperactivity is linked with physical health problems.
Read MoreNew Research Shows Mindfulness Can Reduce Impulsivity
KEY POINTS: Practicing mindfulness can reduce impulsivity and emotional reactivity. Mindfulness includes breathing skills, yoga, pausing, and observing inner and outer experiences. Mindfulness changes the brain through neuroplasticity and changes brain structures related to reactivity.
Read MoreTHC and Adolescents: An Overlooked Issue in Youth Mental Health
Regular THC use in adolescence is not a benign activity—it can have life-changing consequences. Here’s what you need to know.
Read MoreStudy links cord blood lipid levels to early ADHD and autism symptoms
In a recent study published in eBioMedicine, researchers evaluated the relationship between attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) symptomatology and the cord blood lipidome at the age of two years.
Read MoreQ&A: Identifying the barriers to earlier autism and ADHD diagnosis
Diagnostic delay is a major concern for children and young people with autism and attention deficit hyperactivity disorder (ADHD)—and also for their loved ones. The delay is the gap between first concerns about a child’s development, and their eventual diagnosis. In some cases this can be more than five years.
Read MoreTransforming ADHD Care: Viloxazine ER vs Atomoxetine Roundtable Discussion
In this roundtable discussion focused on the “Extended-Release (ER) Viloxazine Compared With Atomoxetine for Attention-Deficit/Hyperactivity Disorder (ADHD)” study published in July 2023 in volume 37 of CNS Drugs, experts Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann examine the evolving ADHD treatment landscape. They compare viloxazine ER with atomoxetine, offering insights into a…
Read MoreWhy are so many adults just now being diagnosed with ADHD?
Rates of adult ADHD have jumped in the last two decades. Researchers are exploring whether 24/7 use of technology may be contributing.
Read More